Wyss InstituteDrug Development – Wyss Institute

Destigmatizing mental health and democratizing brain-related research

Jessica Leff — Wed, 27 May 2026 13:50:06 +0000

By Jessica Leff More than one in five U.S. adults experience mental illness each year, but in 2024, only 52.1% of them received treatment. One reason people are reluctant to seek help is because of the stigma surrounding mental health. Often, that stigma comes from a lack of understanding and fear. Unfortunately, stigma doesn’t only impact those with mental illnesses, but it also affects…

Source

Wyss Institute technologies enable breakthrough in astronaut health research aboard NASA’s Artemis II mission

Jessica Leff — Thu, 09 Apr 2026 14:55:20 +0000

By Alexandra Jirstrand (BOSTON) – Launched on April 1, 2026, Artemis II is a historic, approximately 10-day lunar flyby mission that is sending four astronauts farther into space than any humans have traveled since the Apollo era, marking a critical step toward sustained lunar exploration and future missions to Mars. The Wyss Institute for Biologically Inspired Engineering at Harvard…

Source

Katharina Meyer on improving our understanding and treatment of bipolar disorder

Jessica Leff — Mon, 30 Mar 2026 15:10:58 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Katharina Meyer is exceptionally welcoming in both her personal and professional life. At home, this takes the form of studying and improving hosting skills by experimenting with cooking and…

Source

James Collins: Doing Good Science with an Underdog Spirit – The Pulse Podcast

Jessica Leff — Mon, 16 Mar 2026 17:11:57 +0000

James J. Collins is a founding Core Faculty member at the Wyss Institute and the Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT. Jim serves as a director at the MIT Jameel Clinic, a member of the Harvard-MIT Health Sciences & Technology Faculty, and a member of the Broad Institute. Jim is also an elected member of all three national academies.

Source

Transforming cancer treatments through bioinspired engineering and translation

Jessica Leff — Wed, 04 Feb 2026 14:59:03 +0000

Despite major advances in personalized medicine, targeted drugs, and immunotherapies, many cancers remain difficult – or impossible – to treat. Even when therapies work, they can trigger serious secondary health risks that may themselves become life-threatening. Wyss Institute researchers are tackling these challenges head-on by developing new therapies that more powerfully activate the immune…

Source

Russell Gould on using data to solve problems

Jessica Leff — Tue, 27 Jan 2026 13:45:43 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Russell Gould wants to know why. Seeking a flexible, open career path after serving in the military, he gravitated toward science, where he was encouraged to ask questions about the unknown.

Source

Brain Shuttles: A New Path Into the Brain with James Gorman of the Wyss Institute

Jessica Leff — Tue, 25 Nov 2025 19:34:19 +0000

The host of Business Trip, Matias Serebrinsky, interviews Wyss Senior Director of Translational R&D James (Jim) Gorman, M.D., Ph.D. Jim is a Principal Investigator of the Wyss Institute Brain Targeting Program (BTP). He leads a team developing new approaches to transport drugs through the blood-brain barrier (BBB) into the central nervous system. In this episode, they discuss why the BBB blocks…

Source

Gina Wang on having the NERVE to detect ALS

Jessica Leff — Fri, 21 Nov 2025 14:00:19 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Gina Wang approaches baking the same way she approaches scientific experiments. She tracks different variables and eventually finds the optimal way to bake a chiffon cake or detect abnormal…

Source

Unravel: from tools for studying pathogen tolerance to hope for rare disease patients

Jessica Leff — Thu, 20 Nov 2025 17:49:56 +0000

Part of the Wyss Institute’s series on the positive, life-altering impact of federal research funding By Jessica Leff There are approximately 350 million people in the world with a rare disease, including 25-30 million Americans. About 80% of the disorders are genetic, and 95% of them have no FDA-approved treatments. Finding an effective drug is no small task; after an expensive and long…

Source

How federal funds fuel life-saving innovation

Jessica Leff — Thu, 20 Nov 2025 17:49:40 +0000

Source